1. Home
  2. IOVA vs PRLB Comparison

IOVA vs PRLB Comparison

Compare IOVA & PRLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Proto Labs Inc.

PRLB

Proto Labs Inc.

HOLD

Current Price

$78.94

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
PRLB
Founded
2007
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2008
2011

Fundamental Metrics

Financial Performance
Metric
IOVA
PRLB
Price
$4.08
$78.94
Analyst Decision
Buy
Strong Buy
Analyst Count
10
2
Target Price
$9.00
$53.00
AVG Volume (30 Days)
12.1M
175.3K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
14.84
33.33
EPS
N/A
0.33
Revenue
N/A
N/A
Revenue This Year
$47.74
$8.56
Revenue Next Year
$40.31
$6.89
P/E Ratio
N/A
$236.24
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$37.91
52 Week High
$5.63
$78.68

Technical Indicators

Market Signals
Indicator
IOVA
PRLB
Relative Strength Index (RSI) 53.47 65.26
Support Level $2.07 $47.27
Resistance Level $4.35 N/A
Average True Range (ATR) 0.36 3.00
MACD -0.02 -0.00
Stochastic Oscillator 40.45 94.44

Price Performance

Historical Comparison
IOVA
PRLB

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About PRLB Proto Labs Inc.

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

Share on Social Networks: